Avenue Therapeutics diskutieren

Avenue Therapeutics with positive results from its first Phase 3...

 ... clinical trial assessing IV tramadol for the treatment of patients with moderate-to-moderately severe pain following bunionectomy surgery. The study met the primary endpoint of a statistically valid improvement in pain score over 48 hours compared to placebo. Key secondary endpoints were also met. The results will be submitted for presentation at a future scientific conference or for publication.

A second Phase 3 evaluating IV tramadol patients following abdominoplasty surgery will commence next quarter.